In the classic model of immune system response, naive effector T cells differentiate into two kinds of cells that combat antigens. T helper type 1 (TH1) cells clear intracellular pathogens, while T helper type 2 (TH2) cells control certain parasitic infections. In 2005, Casey Weaver's team at the University of Alabama at Birmingham identified a third class of T helper cell that produces the cytokine interleukin 17 (IL-17) in response to autoimmune tissue injury, which they named TH17 cells. 1





